Bracco Celebrates Personalized and Precision Medicine Innovations at RSNA 2021

(Monroe Township, N.J., USA), the US subsidiary of Bracco Imaging S.p.A., highlighted its personalized and precision medicine innovations during the Radiological Society of North America (RSNA) Annual Meeting held November 28 to December 2.

Bracco offers a product and solution portfolio for all key diagnostic imaging modalities: X-ray imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization), magnetic resonance imaging (MRI), Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers and novel positron emission tomography (PET) imaging agents. The company’s portfolio comprises a range of medical devices, advanced administration systems and dose-management software.

At RSNA 2021, Bracco announced diagnostic imaging, contrast media and informatics achievements that are propelling personalized and precision medicine forward while demonstrating an understanding of the community's needs today. Bracco shared several milestones it has achieved since RSNA 2020 that aim to help advance personalized, value-based care for radiology. For instance, Bracco has secured two U.S. Food and Drug Administration (FDA) approvals, one aiming to help our youngest patients, and the other to increase efficiencies and reduce waste. The company has also established a key partnership aimed at improving patient access to cardiac PET imaging in more diverse patient care sites, including at the community level.

Bracco also provided details of its sponsorship of a new mentorship program with a renowned imaging society aimed at supporting the academic and professional development of imaging professionals throughout their careers. Additionally, Bracco highlighted its efforts to enhance workflows, boost productivity and promote patient-centric care for the radiology community through its largest integrated portfolio of contrast, injectors and informatics solutions that span the diagnostic continuum.

"Virtual opportunities abounded in the last year, but we're thrilled to be in-person at this year's RSNA to nurture connections and demonstrate our continued commitment to the imaging community. The pandemic—and the radiology community's response to it—has undeniably inspired us in our commitment to provide our customers and business partners with the best tools possible to help improve patients' lives," said Cosimo DePinto, Senior Vice President, Sales and Marketing at Bracco Diagnostics Inc. "The future of radiology is more interconnected and personalized than ever, and we're looking to the future to ensure that the challenges radiology professionals face and the insights they share are what drives our solutions."

Related Links:
Bracco Diagnostics Inc.